Search results will open in a new window on

Exchange Bulletin

Avicanna Inc. (AVCN) To Trade On Toronto Stock Exchange

July 16, 2019

Issuer: Avicanna Inc. 

Issuer: Avicanna Inc. (the "Company")
Security: Common shares
Symbol(s): AVCN
Number of securities issued and outstanding: 22,021,806
Number of securities reserved for issuance: 4,810,457
Listing category: Industrial, Non-Exempt Issuer
Trading currency: CDN$
Listing and posted for trading date: July 18, 2019 (at the opening)
Other market(s): None.
Temporary market maker: Altacorp Capital Inc.
Security ownership registration: Non-certificated inventory system of CDS
Investor relations: Davender Sohi (647) 246-5283
Incorporation: Business Corporations Act (Ontario)
Fiscal year end: December 31
Nature of business: The Company aims to establish itself in the global medical cannabis industry through its product discovery and development processes, intellectual property portfolio, strategic relationships and cultivation infrastructure.
Transfer agent and registrar: Odyssey Trust Company at its principal offices in Vancouver and Calgary.
Dividends: None anticipated in the foreseeable future.
Recent Financing: The Company issued 2,228,328 special warrants at a price of $8.00 per special warrant on April 15, 2019. The special warrants were offered by Sprott Capital Partners LP and Paradigm Capital Inc., as agents, and converted, with no additional consideration payable, into 2,228,328 common shares of the Company (the "Shares") and 1,114,164 common share purchase warrants (the "Warrants") at 8:00 a.m. (Toronto time) on Monday, July 15, 2019. The Shares and Warrants are being qualified by the Prospectus.
Sponsorship: Paradigm Capital Inc.
Disclosure document: The Company's non-offering long-form prospectus dated July 8, 2019, which is available at Capitalized terms not otherwise defined herein are as defined in the disclosure document.
TSX contact: Chris Birkett, Director, Toronto Stock Exchange.